Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer

Physics in Medicine and Biology

Volumn 57, Issue 21, 2012, Pages 7117-7132

  Rechner, Laura A ^a,b   Howell, Rebecca M ^a,b   Zhang, Rui ^a,b   Etzel, Carol ^a,b   Lee, Andrew K ^b   Newhauser, Wayne D ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARC THERAPY; EXCESS RELATIVE RISKS; INTENSITY-MODULATED RADIOTHERAPY; PROSTATE CANCERS; PROTON THERAPY; RISK MODEL; VOLUMETRIC MODULATED ARC THERAPY;

PROTONS; RADIOTHERAPY; RISK ASSESSMENT;

DISEASES;

ARTICLE; BLADDER TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MIDDLE AGED; MONTE CARLO METHOD; ORGANS AT RISK; PROSTATE TUMOR; PROTON THERAPY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION SCATTERING; RECTUM TUMOR; RISK;

HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; ORGANS AT RISK; PROSTATIC NEOPLASMS; PROTON THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RISK; SCATTERING, RADIATION; URINARY BLADDER NEOPLASMS;

EID: 84868020450     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/57/21/7117     Document Type: Article

References (59)

1. ACS 2012 Survival rates for prostate cancer American Cancer Society www.cancer.org
2. Baxter N N, Tepper J E, Durham S B, Rothenberger D A and Virnig B A 2005 Increased risk of rectal cancer after prostate radiation: a population-based study Gastroenterology 128 819-24 (Pubitemid 40523534)
3. Bednarz B, Athar B and Xu X G 2010 A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models Med. Phys. 37 1987-94
4. Brenner D J, Curtis R E, Hall E J and Ron E 2000 Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery Cancer 88 398-406 (Pubitemid 30051826)
5. Brenner D J and Hall E J 2008 Secondary neutrons in clinical proton radiotherapy: a charged issue Radiother. Oncol. 86 165-70
6. Bues M, Newhauser W D, Titt U and Smith A R 2005 Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study Radiat. Prot. Dosim. 115 164-9 (Pubitemid 43103404)
7. Bzdusek K, Friberger H, Eriksson K, Hardemark B, Robinson D and Kaus M 2009 Development and evaluation of an efficient approach to volumetric arc therapy planning Med. Phys. 36 2328-39
8. Caporaso G J et al 2008 A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator Phys. Med. 24 98-101
9. Dasu A and Toma-Dasu I 2005 Dose-effect models for risk-relationship to cell survival parameters Acta. Oncol. 44 829-35 (Pubitemid 41780108)
10. Deasy J O, Mackie T R and DeLuca P M 1997 Method and apparatus for proton therapy US Patent Specification US005668371A
11. Flynn R T, Barbee D L, Mackie T R and Jeraj R 2007 Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study Phys. Med. Biol. 52 6073-91 (Pubitemid 350093182)
12. Fontenot J D, Bloch C, Followill D, Titt U and Newhauser W D 2010 Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy Phys. Med. Biol. 55 6987-98
13. Fontenot J D, Lee A K and Newhauser W D 2009 Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 74 616-22
14. Giebeler A 2009 Patient-specific monitor unit determination for patients receiving proton therapy MSc Thesis The University of Texas Health Science Center
15. Hall E J 2004 Henry S Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis Int. J. Radiat. Biol. 80 327-37 (Pubitemid 38943094)
16. Hall E J and Wuu C S 2003 Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int. J. Radiat. Oncol. Biol. Phys. 56 83-8 (Pubitemid 36403679)
17. Howell R M, Scarboro S B, Kry S F and Yaldo D Z 2010a Accuracy of out-of-field dose calculations by a commercial treatment planning system Phys. Med. Biol. 55 6999-7008
18. Howell R M, Scarboro S B, Taddei P J, Krishnan S, Kry S F and Newhauser W D 2010b Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy Phys. Med. Biol. 55 7009-23
19. Huh C H, Bhutani M S, Farfan E B and Bolch W E 2003 Individual variations in mucosa and total wall thickness in the stomach and rectum assessed via endoscopic ultrasound Physiol. Meas. 24 N15-22
20. ICRP 1991 Publication 60, 1990 Recommendations of the International Commission on Radiological Protection Ann. ICRP 21 1-201
21. ICRP 2002 Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals ICRP Publication 89 Ann. ICRP 32 1-280
22. ICRP 2003 Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)) A report of the International Commission on Radiological Protection Ann. ICRP 33 1-80 (Pubitemid 37406660)
23. ICRP 2009 Adult reference computational phantoms ICRP Publication 110 Ann. ICRP 39 1-165
24. ICRU 2007 ICRU Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy J. ICRU 7 1-210
25. Isacsson U, Hagberg H, Johansson K-A, Montelius A, Jung B and Glimelius B 1997 Potential advantages of protons over conventional radiation beams for paraspinal tumours Radiother. Oncol. 45 63-70 (Pubitemid 27448981)
26. Jemal A, Siegel R, Xu J and Ward E 2010 Cancer statistics, 2010 CA Cancer J. Clin. 60 277-300
27. Kendal W, Eapen L and Nicholas G 2007 Second primary cancers after prostatic irradiation: ensuring an appropriate analysis Cancer 109 164 (Author reply 5) (Pubitemid 46120204)
28. Kjaer-Kristoffersen F, Ohlhues L, Medin J and Korreman S 2009 RapidArc volumetric modulated therapy planning for prostate cancer patients Acta. Oncol. 48 227-32
29. Kry S F, Salehpour M, Followill D S, Stovall M, Kuban D A, White R A and Rosen I I 2005 The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 62 1195-203 (Pubitemid 40884435)
30. Lindsay K A, Wheldon E G, Deehan C and Wheldon T E 2001 Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy Br. J. Radiol. 74 529-36 (Pubitemid 32674214)
31. Manieri C, Carter S S, Romano G, Trucchi A, Valenti M and Tubaro A 1998 The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness J. Urol. 159 761-5 (Pubitemid 28106520)
32. Moon K, Stukenborg G J, Keim J and Theodorescu D 2006 Cancer incidence after localized therapy for prostate cancer Cancer 107 991-8 (Pubitemid 44291148)
33. Moyers M F and Miller D W 2003 Range, range modulation, and field radius requirements for proton therapy of prostate cancer Technol. Cancer Res. Treat. 2 445-7 (Pubitemid 37363001)
34. Moyers M F, Miller D W, Bush D A and Slater J D 2001 Methodologies and tools for proton beam design for lung tumors Int. J. Radiat. Oncol. Biol. Phys. 49 1429-38 (Pubitemid 32294322)
35. Newhauser W D and Durante M 2011 Assessing the risk of second malignancies after modern radiotherapy Nat. Rev. Cancer 11 438-48
36. Newhauser W, Fontenot J, Zheng Y, Polf J, Titt U, Koch N, Zhang X and Mohan R 2007 Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm Phys. Med. Biol. 52 4569-84 (Pubitemid 47103143)
37. NRC 2006 Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR-VII National Research Council of the National Academies (Washington DC: The National Academies Press)
38. Oelfke U and Bortfeld T 2000 Intensity modulated radiotherapy with charged particle beams: studies of inverse treatment planning for rotation therapy Med. Phys. 27 1246-57 (Pubitemid 30416092)
39. Otto K 2008 Volumetric modulated arc therapy: IMRT in a single gantry arc Med. Phys. 35 310-7
40. Ronckers C M et al 2006 Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers Radiat. Res. 166 618-28 (Pubitemid 44477715)
41. Ruben J D, Davis S, Evans C, Jones P, Gagliardi F, Haynes M and Hunter A 2008 The effect of intensity-modulated radiotherapy on radiation-induced second malignancies Int. J. Radiat. Oncol. Biol. Phys. 70 1530-6
42. Sandison G A, Papiez E, Bloch C and Morphis J 1997 Phantom assessment of lung dose from proton arc therapy Int. J. Radiat. Oncol. Biol. Phys. 38 891-7 (Pubitemid 27310561)
43. Schneider U and Kaser-Hotz B 2005 A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy Z. Med. Phys. 15 31-7 (Pubitemid 40460415)
44. Schneider U, Lomax A, Besserer J, Pemler P, Lombriser N and Kaser-Hotz B 2007 The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 68 892-7 (Pubitemid 46818764)
45. Schneider U, Lomax A, Pemler P, Besserer J, Ross D, Lombriser N and Kaser-Hotz B 2006 The impact of IMRT and proton radiotherapy on secondary cancer incidence Strahlenther. Onkol. 182 647-52 (Pubitemid 44657651)
46. Schneider U, Zwahlen D, Ross D and Kaser-Hotz B 2005 Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose Int. J. Radiat. Oncol. Biol. Phys. 61 1510-5 (Pubitemid 40470435)
47. SEER 2007 Surveillance Epidemiology and End Results (http://seer.cancer. gov)
48. Sengbusch E, Perez-Andujar A, DeLuca P M Jr and Mackie T R 2009 Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy Med. Phys. 36 364-72
49. Siegel R, Ward E, Brawley O and Jemal A 2011 Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J. Clin. 61 212-36
50. Sigurdson A J et al 2005 Primary thyroid cancer after a first tumour in childhood (the childhood cancer survivor study): a nested case-control study Lancet 365 2014-23 (Pubitemid 40805009)
51. Smart D R 2009 Physician characteristics and distribution in the US, 2010 Am. Med. Assoc. 1 1-366
52. SSA 2012 Actuarial life table www.ssa.gov
53. Taddei P J, Fontenot J D, Zheng Y, Mirkovic D, Lee A K, Titt U and Newhauser W D 2008 Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer Phys. Med. Biol. 53 2131-47 (Pubitemid 351605990)
54. Teoh M, Clark C H, Wood K, Whitaker S and Nisbet A 2011 Volumetric modulated arc therapy: a review of current literature and clinical use in practice Br. J. Radiol. 84 967-96
55. Travis L B et al 2005 Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J. Natl Cancer Inst. 97 1428-37 (Pubitemid 41520078)
56. Wijesooriya K, Bartee C, Siebers J V, Vedam S S and Keall P J 2005 Determination of maximum leaf velocity and acceleration of a dynamic multileaf collimator: implications for 4D radiotherapy Med. Phys. 32 932-41 (Pubitemid 40586778)
57. Yu C X 1995 Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy Phys. Med. Biol. 40 1435-49
58. Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M and Mageras G 2009 Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases Int. J. Radiat. Oncol. Biol. Phys. 76 1456-62
59. Zheng Y, Fontenot J, Taddei P, Mirkovic D and Newhauser W 2008 Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit Phys. Med. Biol. 53 187-201